Related Experiment Video
Updated: Jan 29, 2026

A Calcium Bioluminescence Assay for Functional Analysis of Mosquito Aedes aegypti and Tick Rhipicephalus microplus G Protein-coupled Receptors
Published on: April 20, 2011
Small-Molecule Agonists of Ae. aegypti Neuropeptide Y Receptor Block Mosquito Biting.
Laura B Duvall1, Lavoisier Ramos-Espiritu2, Kyrollos E Barsoum1
1Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065, USA.
Researchers discovered a new way to suppress mosquito attraction to humans using drugs targeting neuropeptide Y-like receptor 7 (NPYLR7). This finding offers a novel strategy for controlling mosquito-borne diseases.
Area of Science:
- Neuroscience
- Entomology
- Pharmacology
Background:
- Female Aedes aegypti mosquitoes exhibit a strong attraction to humans for blood-feeding, crucial for egg development.
- This host-seeking behavior is temporarily suppressed after a blood meal through an unknown mechanism.
Purpose of the Study:
- To investigate the role of neuropeptide Y (NPY)-related signaling in the long-term behavioral suppression of host-seeking in Aedes aegypti.
- To identify specific receptors and develop small-molecule agonists that can modulate mosquito behavior for disease control.
Main Methods:
- Screened 49 predicted Aedes aegypti peptide receptors to identify NPY-like receptor 7 (NPYLR7) as a key target.
- Conducted a high-throughput screening of 265,211 compounds to find selective NPYLR7 agonists.
- Utilized CRISPR-Cas9 gene editing to create NPYLR7 null mutants for functional analysis.
Main Results:
- Identified NPYLR7 as the sole target of drugs that modulate mosquito host-seeking behavior.
- Isolated six highly selective NPYLR7 agonists that effectively inhibit mosquito attraction to humans.
- Demonstrated that NPYLR7 null mutants are impaired in behavioral suppression and resistant to the developed drugs.
Conclusions:
- Neuropeptide Y-related signaling, specifically through NPYLR7, plays a critical role in suppressing mosquito attraction post-blood meal.
- Developed selective NPYLR7 agonists offer a promising novel approach to control mosquito behavior and reduce infectious disease transmission.
- The study highlights the potential of targeting mosquito neurobiology for effective vector control strategies.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Internal Receptors
Receptor-mediated Endocytosis

